Harler Mary Beth — SEC Form 4 filings

SEC reporting owner CIK 2018699. 9 Form 4 filings on record with FilingPulse; latest filed 2025-08-14.

Transaction summary — filings shown

Covers all 9 filings on record, filed 2024-06-18 to 2025-08-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
IGM Biosciences, Inc. (IGMS)Chief Executive Officer, Director96 legs · 28,117 sh · $71,1246

Form 4 filings — Harler Mary Beth

FiledFormIssuerReported transactionsSource
2025-08-144IGM Biosciences, Inc. (IGMS)Disposition to issuer (D): 323,680EDGAR
2025-07-254IGM Biosciences, Inc. (IGMS)Sale (S): 14,501 @ $1.27EDGAR
2025-06-204IGM Biosciences, Inc. (IGMS)Sale (S): 1,522 @ $1.20EDGAR
2025-03-184IGM Biosciences, Inc. (IGMS)Sale (S): 7,329 @ $1.23EDGAR
2024-12-184IGM Biosciences, Inc. (IGMS)Sale (S): 1,708 @ $7.48EDGAR
2024-10-044IGM Biosciences, Inc. (IGMS)Grant/award (A): 185,000 @ $0 · Grant/award (A): 370,000 (derivative) @ $0EDGAR
2024-09-174IGM Biosciences, Inc. (IGMS)Sale (S): 1,487 @ $11.54EDGAR
2024-07-234IGM Biosciences, Inc. (IGMS)Grant/award (A): 54,999 · Grant/award (A): 25,001 · Disposition to issuer (D): 200,000 (derivative)EDGAR
2024-06-184IGM Biosciences, Inc. (IGMS)Sale (S): 1,570 @ $7.58EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2018699 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →